146 research outputs found
Melkites, Mutakallim?n and al-Ma’m?n: Depicting the Religious Other in Medieval Arabic Dialogues
No full textThe article describes a literary dialogue said to have occurred in 829/214 between the Arab Melkite Christian bishop Theodore Ab? Qurra, several Muslim scholars, and the caliph al-Ma’m?n. The text contains two types of dialogue: Ab? Qurra versus the Muslim scholars and Ab? Qurra with al-Ma’m?n. The former is distinguished by its antagonism on both sides, while the latter is noted for its polite discourse. The evidence indicates that the Muslim caliph al-Ma’m?n held an admired place in the Melkite Christian community’s memory. The author’s analysis concludes that the dialogue presupposes Christian Arab identity was integrated into the dominant Islamic culture in a symbiotic relationship that recognized the reality of religious pluralism and disparate truth claims. The author also argues that the text placed value on the dialogical approach as a process of identity formation by constructing boundaries with religious others while simultaneously internalizing these other religious worldviews.</jats:p
Correction: Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?—A multicenter EBMT-PDWP study (Bone Marrow Transplantation, (2020), 55, 8, (1540-1551), 10.1038/s41409-020-0854-0)
No full textThe article “Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?—A multicenter EBMT-PDWP study,” written by Andre Manfred Willasch, Christina Peters, Petr Sedláček, Jean-Hugues Dalle, Vassiliki Kitra-Roussou, Akif Yesilipek, Jacek Wachowiak, Arjan Lankester, Arcangelo Prete, Amir Ali Hamidieh, Marianne Ifversen, Jochen Buechner, Gergely Kriván, Rose-Marie Hamladji, Cristina Diaz-de-Heredia, Elena Skorobogatova, Gérard Michel, Franco Locatelli, Alice Bertaina, Paul Veys, Sophie Dupont, Reuven Or, Tayfun Güngör, Olga Aleinikova, Sabina Sufliarska, Mikael Sundin, Jelena Rascon, Ain Kaare, Damir Nemet, Franca Fagioli, Thomas Erich Klingebiel, Jan Styczynski, Marc Bierings, Kálmán Nagy, Manuel Abecasis, Boris Afanasyev, Marc Ansari, Kim Vettenranta, Amal Alseraihy, Alicja Chybicka, Stephen Robinson, Yves Bertrand, Alphan Kupesiz, Ardeshir Ghavamzadeh, Antonio Campos, Herbert Pichler, Arnaud Dalissier, Myriam Labopin, Selim Corbacioglu, Adriana Balduzzi, Jacques-Emmanuel Galimard, Peter Bader, on behalf of the EBMT Paediatric Diseases Working Party, was originally published online first without Open Access. After publication in volume 55, issue 8, page 1540–1551, the author decided to opt for Open Choice and to make the article an Open Access publication. Therefore, the copyright of the article has been changed to © The Author(s) 2020 and the article is forthwith distributed under the terms of the Creative Commons Attribution 4.0 InternationalS License, which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third-party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/ 4.0. Open access funding was enabled and organized by Projekt DEAL
Author Correction:Experimental protection of quantum coherence by using a phase-tunable image drive (Scientific Reports, (2020), 10, 1, (21643), 10.1038/s41598-020-77047-5)
No full textThe original version of this Article contained an error.</p
Simulation study of the detected and expected events for the EUSO-TA fluorescence detector
No full textThe JEM-EUSO Project: Observing Extremely High Energy Cosmic Rays and Neutrinos from the International Space Station
No full textThe Japanese Experiment Module - Extreme Universe Space Observatory (JEM-EUSO) is a
super wide-field telescope to observe Extremely High Energy Cosmic Rays (EHECR) and neutrinos with energy above 1019eV from the International Space Station (ISS), orbiting at an altitude of about 430 km from ground. JEM-EUSO will image the fluorescence light emitted by the atmospheric molecules of nitrogen excited during the development of the Extensive Air Shower (EAS) generated by the interaction of a EHECR or neutrino at the top of the atmosphere. It will also detect part of the ˇCerenkov light produced during the shower development and reflected at the impact point (land, sea or clouds).journal articl
The JEM-EUSO Project: Observing Extremely High Energy Cosmic Rays and Neutrinos from the International Space Station
No full textCorrection to: NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL (Leukemia, (2018), 32, 3, (633-644), 10.1038/leu.2017.294)
No full textThe original version of this Article contained an error in the spelling of the author Juan Carlos Rodriguez-Manzaneque, which was incorrectly given as J Carlos Rodríguez-Manzaneque. This has now been corrected in both the PDF and HTML versions of the Article
Erratum: Search for photons with energies above 1018 eV using the hybrid detector of the Pierre Auger Observatory
No full text1 Exposure calculation Due to a mistake in the numerical integration following eq. (6.2) of the original article [1], the exposure shown in figure 5 of the original article was incorrect. The correct exposure is shown in figure 1. 2 Upper limits on the integral photon flux and fraction The incorrect exposure affects the calculation of the upper limits on the integral photon flux following eq. (6.1) of the original article. The correct values for the upper limits are 0.038, 0.010, 0.009, 0.008 and 0.007 km−2 sr−1 yr−1 for threshold energies of 1, 2, 3, 5 and 10 EeV. The correct values for the upper limits on the integral photon fraction subsequently derived are 0.14 %, 0.17 %, 0.42 %, 0.86 % and 2.9 % for the same threshold energies. 3 Author list The author list of this erratum also corrects a mistake made in the original article, where F. Zuccarello was missing and Z. Zong was listed twice.Fil: Aab, A.. Radboud Universiteit Nijmegen; Países BajosFil: Abreu, P.. Instituto Superior Tecnico; PortugalFil: Aglietta, M.. Istituto Nazionale di Astrofisica; Italia. Istituto Nazionale di Fisica Nucleare; ItaliaFil: Al Samarai, I.. Laboratoire de Physique Nucléaire Et de Hautes Energies; FranciaFil: Albuquerque, I. F. M.. Universidade de Sao Paulo; BrasilFil: Allekotte, Ingomar. Comisión Nacional de Energía Atómica. Gerencia del Área de Energía Nuclear. Instituto Balseiro; ArgentinaFil: Almela, A.. Comisión Nacional de Energía Atómica. Centro Atómico Constituyentes; Argentina. Universidad Tecnológica Nacional; ArgentinaFil: Alvarez Castillo, J.. Universidad Nacional Autónoma de México; MéxicoFil: Alvarez-Muñiz, J.. Universidad de Santiago de Compostela; EspañaFil: Anastasi, G. A.. Istituto Nazionale di Fisica Nucleare; ItaliaFil: Anchordoqui, Luis A.. City University of New York; Estados UnidosFil: Andrada, B.. Comisión Nacional de Energía Atómica. Centro Atómico Constituyentes; ArgentinaFil: Andringa, S.. Instituto Superior Tecnico; PortugalFil: Aramo, C.. Istituto Nazionale di Fisica Nucleare; ItaliaFil: Arqueros, F.. Universidad Complutense de Madrid; EspañaFil: Arsene, N.. University of Bucharest; RumaniaFil: Asorey, Hernán Gonzalo. Universidad Industrial Santander; Colombia. Comisión Nacional de Energía Atómica. Gerencia del Área de Energía Nuclear. Instituto Balseiro; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Assis, P.. Instituto Superior Tecnico; PortugalFil: Aublin, J.. Laboratoire de Physique Nucléaire Et de Hautes Energies; FranciaFil: Avila, G.. Observatorio Pierre Auger And Comisión Nacional de Energía Atómica; Argentina. Observatorio Pierre Auger; ArgentinaFil: Badescu, A. M.. University Politehnica Of Bucharest; RumaniaFil: Balaceanu, A.. “Horia Hulubei” National Institute for Physics and Nuclear Engineering; RumaniaFil: Barreira Luz, R. J.. Instituto Superior Tecnico; PortugalFil: Beatty, J. J.. Ohio State University; Estados UnidosFil: Becker, K. H.. Bergische Universität Wuppertal; AlemaniaFil: Bellido, J.A.. University of Adelaide; AustraliaFil: Berat, C.. Université Grenoble Alpes; FranciaFil: Bertaina, M. E.. Università di Torino; Italia. Istituto Nazionale di Fisica Nucleare; ItaliaFil: Bertou, Xavier Pierre Louis. Comisión Nacional de Energía Atómica. Gerencia del Área de Energía Nuclear. Instituto Balseiro; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Sciutto, Sergio Juan. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Instituto de Física La Plata. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Instituto de Física La Plata; Argentin
Multiple infusions of mesenchymal stromal cells induce sustained remission in children with steroid-refractory, grade III-IV acute graft-versus-host disease.
No full textMesenchymal stromal cell (MSC) infusions have been reported to be effective in patients with steroid-refractory, acute graft-versus-host disease (aGvHD) but comprehensive data on paediatric patients are limited. We retrospectively analysed a cohort of 37 children (aged 3 months-17 years) treated with MSCs for steroid-refractory grade III-IV aGvHD. All patients but three received multiple MSC infusions. Complete response (CR) was observed in 24 children (65\%), while 13 children had either partial (n = 8) or no response (n = 5). Cumulative incidence of transplantation-related mortality (TRM) in patients who did or did not achieve CR was 17\% and 69\%, respectively (P = 0.001). After a median follow-up of 2.9 years, overall survival (OS) was 37\%; it was 65\% vs. 0\% in patients who did or did not achieve CR, respectively (P = 0.001). The median time from starting steroids for GvHD treatment to first MSC infusion was 13 d (range 5-85). Children treated between 5 and 12 d after steroid initiation showed a trend for better OS (56\%) and lower TRM (17\%) as compared with patients receiving MSCs 13-85 d after steroids (25\% and 53\%, respectively; P = 0.22 and 0.06, respectively). Multiple MSC infusions are safe and effective for children with steroid-refractory aGvHD, especially when employed early in the disease course
Correction: NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL.
No full textThe original version of this Article contained an error in the spelling of the author Juan Carlos Rodriguez-Manzaneque, which was incorrectly given as J Carlos Rodríguez-Manzaneque. This has now been corrected in both the PDF and HTML versions of the Article
- …
